Item 5.02
Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
Effective as of August 15, 2016, the Board of Directors (the
“Board”) of WPCS International Incorporated (the “Company”) appointed Joshua Silverman to fill a newly
created vacancy on the Board.
Mr. Silverman was appointed pursuant to a Nomination, Standstill
and Voting Agreement (the “Agreement”) between the Company and the persons and entities listed in Schedule A to the
Agreement (the “Iroquois Group”). Under the Agreement, the Company agreed to appoint Mr. Silverman as a member of the
Board to fill a newly created vacancy and agreed to include him in its slate of nominees for election as directors of the Company
at the 2016 annual meeting of stockholders (the “2016 Annual Meeting”). The Iroquois Group agreed to refrain from certain
activities at the 2016 Annual Meeting and until such time as Mr. Silverman is no longer serving as a member of the Board and further
agreed to vote for the Company slate of directors and according to the Company’s recommendation for other items of business
at the 2016 Annual Meeting, subject to certain exceptions. The foregoing summary of the Agreement does not purport to be complete,
and is qualified in its entirety by reference to the Agreement filed as
Exhibit 99.1
hereto.
From 2003 until July 2016, Mr. Silverman served as the Managing
Partner and Co-Chief Investment Officer of Iroquois Capital Management LLC (“Iroquois Capital”) and as managing member
of Iroquois Capital Investment Group LLC (“ICIG”). Based upon a Schedule 13D/A filed August 2, 2016, Mr. Silverman
and other members of the Iroquois Group were a “group” for purposes of Section 13(d)(3) of the Securities Exchange
Act of 1934, as amended, consisting of Iroquois Capital, ICIG, Iroquois Master Fund, Ltd. (“IMF”), American Capital
Management, LLC (“American Capital”), Richard Abbe, and Kimberly Page.
On July 15, 2015, the Company entered into a Securities Purchase
Agreement with each of IMF, ICIG, and American Capital, pursuant to which the Company issued to each of IMF, ICIG, and American
Capital, Series H-1 preferred shares and certain warrants to purchase shares of the Company’s common stock, with an exercise
price of $1.66 per share of common stock.
On June 30, 2015, the Company entered into Amendment, Waiver
and Exchange Agreements (the “Exchange Agreements”) with each of IMF and American Capital. Pursuant to the terms of
the Exchange Agreements, IMF and American Capital each agreed to exchange all of the Company’s then-existing indebtedness
to each of IMF and American Capital, and in return, the Company agreed to issue Series H preferred shares to each of IMF and American
Capital.
On November 20, 2014, the Company entered into Amendment, Waiver
and Exchange Agreements (the “November Exchange Agreements”) with each of IMF and American Capital. Pursuant to the
terms of the November Exchange Agreements, each of IMF and American Capital exchanged (i) senior secured convertible notes under
that certain 2012 Securities Purchase Agreement, dated December 4, 2012, for Series F-1 preferred shares, (ii) Series E preferred
shares for promissory notes and Series G-1 preferred shares, and (iii) certain warrants to acquire shares of the Company’s
common stock for Series G-1 preferred shares.
There are no family relationships between any of the Company’s
directors or officers and Mr. Silverman.
For his services as a member of the Board, Mr. Silverman will
receive $24,000 per year. He will also be entitled to receive discretionary cash bonuses and stock options under the Company’s
stock option plans as determined by the Board.